Oral Antineoplastic Agents: Assessing the Delay in Care
| Autor: | Michael Newton, Brandi Anders, Alexandra Shillingburg |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Receipt
medicine.medical_specialty Article Subject business.industry Alternative medicine Pharmacy General Medicine Insurance type computer.software_genre Risk evaluation & mitigation strategies Emergency medicine Medicine Prior authorization Data mining Patient assistance Medical prescription business computer Research Article |
| Zdroj: | Chemotherapy Research and Practice |
| ISSN: | 2090-2115 2090-2107 |
| DOI: | 10.1155/2015/512016 |
| Popis: | The study was undertaken to determine the length of time between when a prescription for an oral antineoplastic agent is written by the provider and when the medication is received by the patient and to identify risk factors that significantly increase time to medication receipt. First-time fill prescriptions for oral antineoplastic agents were identified. The date the prescription was written and received by the patient was determined. A retrospective review was completed to gather additional information, including prescribed medication, indication, insurance coverage, patient assistance program use, dispensing pharmacy, and prior authorization requirements. The data was analyzed through multivariate statistical analysis and used to identify risk factors that may significantly increase the time to medication receipt. A total of 58 patients were included in the study. A median of 8 days elapsed between when the medication was prescribed and when it was received by the patient. Medication prescribed, absence of a Risk Evaluation Mitigation Strategies (REMS) program, and insurance type are factors that increased time to medication receipt. An understanding of the median time involved, as well as factors affecting the time to delivery of prescriptions, will help healthcare providers better plan and prepare for the use of oral antineoplastic agents. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|